-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

723.O1.6 723. Allogeneic Transplantation: Long-Term Follow up and Disease Recurrence: Novel Therapies to Prevent and Treat Disease Relapse

Symposia: Allogeneic Transplantation: Long-term Follow-up, Complications, and Disease Recurrence Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Clinical trials, Lymphoid Leukemias, ALL, Acute Myeloid Malignancies, AML, MDS, Adult, Combination therapy, MPN, Clinical Research, Chronic Myeloid Malignancies, CMML, Diseases, Treatment Considerations, Biological therapies, Lymphoid Malignancies, Registries, Myeloid Malignancies, Study Population, Human, Measurable Residual Disease , Transplantation (Allogeneic and Autologous)
Monday, December 9, 2024: 4:30 PM-6:00 PM
Room 6A (San Diego Convention Center)
Moderators:
Gabriela Sanchez-Petitto, MD, The Ohio State University and Simona Pagliuca, MD, PhD, Nancy University Hospital
Disclosures:
Sanchez-Petitto: GamidaCell: Consultancy; Bristol-Myers Squibb: Research Funding. Pagliuca: Alexion: Consultancy, Honoraria; Sobi: Consultancy, Honoraria; Novartis: Consultancy, Honoraria; Jazz: Consultancy, Honoraria.

This session consists of abstracts describing clinical trials of maintenance therapy after allogeneic hematopoietic cell transplant as well as treatment of relapsed disease after treatment.
4:30 PM

Jacqueline S. Garcia, MD1, Haesook T. Kim, PhD2, Jennifer Brock1*, H. Moses Murdock, MD1, Mahasweta Gooptu, MD3, Vincent T. Ho, MD1*, Roman M. Shapiro, MD4, Christopher J. Gibson, MD5, Amar H. Kelkar, MD, MPH, FACP1, Corey S. Cutler, MD, MPH1, Denbaa Bat-Erdene1*, Jeremy Ryan, MS6*, Anna Bosch-Vilaseca, MD1*, Anthony G. Letai6, Jerome Ritz, MD1, Coleman Lindsley, MD, PhD1, Robert J. Soiffer, MD1 and Joseph Antin, MD1*

1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
2Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
3Department of Hematology/Oncology, Dana-Farber Cancer Institute, Boston, MA
4Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
5Department of Medical Oncology, Dana-Farber Cancer Institute, Boston
6Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

4:45 PM

David Sallman, MD1, Amy F McLemore, MS2*, Rami S. Komrokji, MD3, Hany Elmariah, MD, MS4, Andrew T. Kuykendall, MD1, Nelli Bejanyan, MD4, Onyee Chan, MD5*, Rawan Faramand, MD6, Joseph A. Pidala, MD, PhD4, Sean J. Yoder, MS7*, Lia Perez, MD4*, Taiga Nishihori, MD8, Eric Padron, MD1, Hugo Francisco Fernandez, MD9*, Jeffrey E Lancet, MD1 and Asmita Mishra, MD, MBA4

1Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
2Malignant Hematology Department, Moffitt Cancer Center, Tampa, FL
3Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
4Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
5H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
6Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL
7Molecular Genomics Core Facility, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
8Moffitt Cancer Center, Tampa, FL
9Moffitt Malignant Hematology and Cellular Therapy, Pembroke Pines, FL

5:00 PM

Gheath Alatrash, PhD, DO1,2, Cristina Knape3*, Laura Whited, PharmD4, Dawen Sui, MS5*, Cara L Haymaker, PhD6*, Jason Yeh, pharmd4*, Megan Marcotulli, MS, PA-C4*, Pariya Sukhumalchandra2*, Lisa St. John, PhD7*, Hsinyi Lu8*, Daniela E. Duenas, MD6*, Ignacio Wistuba, MD9*, Julia Mendoza Perez8*, Beatriz Sanchez Espiridion8*, Roland L. Bassett, MS5*, Tapan M. Kadia, MD10, Courtney D. DiNardo, MD, MSc11, Farhad Ravandi, MBBS12, Jeremy Ramdial, MD1, Rohtesh S. Mehta, MD, MPH1*, Amin M. Alousi, MD1*, Betul Oran, MD, MS1, Issa F. Khouri, MD1, Qaiser Bashir, MD1, Chitra Hosing, MD1, Muzaffar H. Qazilbash, MD1, Jin S. Im, MD, PhD1, Partow Kebriaei, MD13, Pavan Bachireddy, MD14, Jeffrey J. Molldrem, MD15, Jeffrey L. Jorgensen, MD16, Sa A. Wang, MD16, Wei WANG17*, Uday Popat, MD1, Elizabeth J. Shpall, MD1, Richard E. Champlin, MD1, Hagop M. Kantarjian, MD10 and Naval Daver, MD18

1Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston
3The University of Texas MD Anderson Cancer Center, Houston
4University of Texas MD Anderson Cancer Center, Houston, TX
5Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
6Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX
7Department of Hematopoietic Biology and Malignancy, University of Texas M. D. Anderson Cancer Center, Houston, TX
8University of Texas MD Anderson Cancer Center, Houston
9Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX
10Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
11Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX
12Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX
13M.D. Anderson Cancer Center, Houston, TX
14Department of Hematopoietic Biology & Malignancy, The University of Texas M.D. Anderson Cancer Center, Houston, TX
15Departments of Hematopoietic Biology and Malignancy, The University of Texas MD Anderson Cancer Center, Houston, TX
16Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
17Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Harbin, China
18MD Anderson Cancer Center, Houston, TX

5:15 PM

Hany Elmariah, MD, MS1, Jongphil Kim, PhD2*, Eric Hornfeck3*, Maria Urdiales Kouba3*, Farhad Khimani, MD1*, Rawan Faramand, MD3, Sayeef Mirza, MD, MPH3, Joseph A. Pidala, MD, PhD1, Andrew T. Kuykendall, MD4, Rami S. Komrokji, MD4, Eric Padron, MD4, David Sallman, MD4, Alison R. Walker, MD, MBA, MPH4, Jeffrey E Lancet, MD4, Asmita Mishra, MD, MBA3, Jose L. Ochoa-Bayona, MD3*, Lia Perez, MD1*, Michael Nieder, MD1*, Claudio Anasetti, MD3*, Nelli Bejanyan, MD3 and Taiga Nishihori, MD3

1Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
2Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL
3Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
4Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL

5:30 PM

Jie Ji, MD, PhD1*, Zhigang Liu, MD, PhD2*, Xinchuan Chen, MD, PhD2*, Pu Kuang, MD3*, Tian Dong, MD, PhD4*, Hang Zhang, MD5*, Ting Niu Sr., MD, PhD6 and Ting Liu7

1Department of Hematology and Institute of Hematology, Department of Hematology, West China Hospital of Sichuan University, Chengdu, China
2Department of Hematology, West China Hospital, Sichuan University, Chengdu, China
3West China Hospital, Sichuan University, Chengdu, CHN
4West China Hospital of Sichuan University, Chengdu, China, Chengdu, CHN
5Department of Hematology and Institute of Hematology, West China Hospital, Sichuan University, Chengdu, China
6Department of Haematology,West China Hospital of Sichuan University, Chengdu, China
7Department of Hematology, West China Hospital of Sichuan University, Chengdu, China

5:45 PM

Chuting Yang1*, Rui Huang, MD1*, Danian Nie, MD2*, Yiqing Li2*, Yuming Zhang, M.D.3*, Honghua He, M.D.4*, Chaoyang Song1*, Sanfang Tu1*, Yaling Zheng1*, Xuan Zhou, MD1*, Jie Chen5*, Hui Zeng, MD, PhD6 and Yuhua Li1*

1Department of Hematology, Zhujiang Hospital of Southern Medical University, Guangzhou, China
2Department of Hematology, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Guangzhou, China
3Department of Hematology, The Affiliated Hospital of Guangdong Medical University, Guangzhou, China
4Department of Hematology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China
5Department of Hematology, The First Affiliated Hospital of Jinan University, Guangzhou, China
6Department of Hematology, Guangdong Provincial People's Hospital, Guangzhou, China

*signifies non-member of ASH